Videos

The Many Consequences of Insomnia

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided background on the momentum behind MR fingerprinting and its potential in epilepsy care. [WATCH TIME: 3 minutes]

Michael J. Thorpy, MD;Karl Doghramji, MD;Erinn E. Beagin, MD;Nathaniel Fletcher Watson, MD;Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE

Considering Sleep Studies for Insomnia

Panelists discuss the broad range of impact insomnia has on a patient’s health and quality of life.

Michael J. Thorpy, MD;Karl Doghramji, MD;Erinn E. Beagin, MD;Nathaniel Fletcher Watson, MD;Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE

Pros and Cons of Telemedicine for Multiple Sclerosis: Mitzi Joi Williams, MD

A brief review of the value of polysomnography, or sleep studies, in diagnosing patients with insomnia.

Mitzi Joi Williams, MD

Information Sharing, Collaboration in MS Care Amidst the COVID-19 Pandemic: Mitzi Joi Williams, MD

The founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her reasoning as to why she hopes telemedicine is here to stay. [WATCH TIME: 4 minutes]

Mitzi Joi Williams, MD

January 9th 2022

Awake vs Asleep DBS Impact, Worsened MS Following DMT Discontinuation, Anticoagulation Noninferior to Avoiding it

Discussing the willingness to share data during the pandemic, the founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center spoke to the positive effect of collaboration in the MS field. [WATCH TIME: 2 minutes]

January 8th 2022

Addressing Health Disparities in the US Following COVID-19: Mitzi Joi Williams, MD

Neurology News Network for the week ending January 8, 2022. [WATCH TIME: 3 minutes]

Mitzi Joi Williams, MD

Headache Specialists for Preventative Migraine Treatments

The founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center commented on the effect of the pandemic on needs for underrepresented populations in the multiple sclerosis space, as well as the pros and cons of telehealth. [WATCH TIME: 3 minutes]

Jessica Ailani, MD;Stephanie J. Nahas, MD, MSEd;Rebecca Erwin Wells, MD, MPH;Christopher Gottschalk, MD;Andrew C. Charles, MD

Preventative Migraine Therapies: The ADVANCE Trial and the Future

A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.

Jessica Ailani, MD;Rebecca Erwin Wells, MD, MPH;Christopher Gottschalk, MD;Stephanie J. Nahas, MD, MSEd;Andrew C. Charles, MD

Monoclonal Antibodies in Development for Alzheimer Disease: Anton Porsteinsson, MD

Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.

Anton P. Porsteinsson, MD

Enacting Necessary Changes to the MS Care Model: Mona Bostick, RDN, LDN, MSCS

The director of the Alzheimer's Disease Care, Research and Education Program at the University of Rochester offered an extensive overview of 3 monoclonal antibodies in development for Alzheimer disease. [WATCH TIME: 9 minutes]

Aducanumab’s Approval for the Treatment of AD

Discussing adaptations to the comprehensive care model in multiple sclerosis, the founder of MS Bites commented on the need to consistently incorporate dietitians. [WATCH TIME: 6 minutes]

Biomarker Assessments and Diagnosing AD

Jeffrey L. Cummings, MD, ScD, discusses the importance of aducanumab, a recently approved treatment for Alzheimer’s disease.

Tailoring Cognitive Behavioral Therapy to PNES, Seizure-Related Disorders, Becky Tilahun, PhD

Jeffrey L. Cummings, MD, ScD, delves into the biomarker assessments that establish a diagnosis of Alzheimer’s disease and their use in clinical practice.

Becky Tilahun, PhD

Dispelling Myths About Dietitians in Multiple Sclerosis Care: Mona Bostick, RDN, LDN, MSCS

The clinical psychologist at Cleveland Clinic discussed the process for successfully changing and tailoring different cognitive behavioral therapy approaches to treat various forms of seizures. [WATCH TIME: 3 minutes]

Eliminating Wasteful Costs in Alzheimer Drug Development: Jeffrey Cummings, MD, ScD

The founder of MS Bites discussed the role of referrals both to and from dietitians, as well as the common misconception that their services are not covered by insurance. [WATCH TIME: 2 minutes]

Jeffrey Cummings, MD, ScD

Managing Patients With RRMS on Novel Oral Therapy

The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas detailed the steps necessary to lower wasted costs from Alzheimer disease drug development and improve regulatory success. [WATCH TIME: 4 minutes]

RRMS: Patient Prognosis and Treatment Planning

Key takeaways from a larger discussion surrounding the utilization of novel oral agents as therapy for patients with relapsing-remitting multiple sclerosis.

Assessing Response to Novel Oral Therapies in RRMS

The patient factors and other variables that impact first-line treatment decisions in relapsing-remitting multiple sclerosis.

The Variation in Migraine Management in Emergency Departments: Anne-Maree Kelly, MD

The types of tests used to monitor response to novel oral therapies used in relapsing-remitting multiple sclerosis.

Anne-Maree Kelly, MD

January 4th 2022

Understanding Cognitive Decline Based on Multiple Sclerosis Phenotype: Dejan Jakimovski, MD, PhD

The director of the Joseph Epstein Center for Emergency Medicine Research provided context on the types of research needed to further evaluate and improve diagnosis and management of headache in emergency departments. [WATCH TIME: 3 minutes]

Dejan Jakimovski, MD, PhD

January 4th 2022

Differentiating Diet Approaches in Multiple Sclerosis: Mona Bostick, RDN, LDN, MSCS

Preventing TSC By Treating at the Earliest Stage: Darcy Krueger, MD, PhD

The founder of MS Bites discussed the role dietitians can play in care of patients with MS, noting that they have not historically been included in the comprehensive care team, and differentiating their approaches to care. [WATCH TIME: 2 minutes]

Darcy Krueger, MD, PhD

Understanding the Causes and Prevalence of Insomnia

The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the thought behind STOPS2, a trial aimed at preventing or delaying seizure onset in tuberous sclerosis complex. [WATCH TIME: 3 minutes]

Michael J. Thorpy, MD;Karl Doghramji, MD;Erinn E. Beagin, MD;Nathaniel Fletcher Watson, MD;Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE

Optimizing a Diagnostic Work-up of Insomnia

A panel of experts break down the myriad of insomnia causes, discussing prevalence amid different patient populations.

Michael J. Thorpy, MD;Karl Doghramji, MD;Erinn E. Beagin, MD;Nathaniel Fletcher Watson, MD;Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE

Shifts in Multiple Sclerosis Care, Ongoing Integration of Telehealth: Mona Bostick, RDN, LDN, MSCS

Considerations for how to optimally work up and diagnose patients with insomnia.

January 2nd 2022

Neurology News Network: Top FDA Approvals of 2021

The registered dietitian and founder of MS Bites spoke on changes in symptom care for patients with MS, as well as the sustained benefits of telehealth. [WATCH TIME: 2 minutes]

January 1st 2022

Oral Agents for Preventative Migraine Treatment

Neurology News Network for the week ending January 1, 2022. [WATCH TIME: 4 minutes]

Jessica Ailani, MD;Andrew C. Charles, MD;Stephanie J. Nahas, MD, MSEd;Christopher Gottschalk, MD;Rebecca Erwin Wells, MD, MPH

December 31st 2021

CGRP Monoclonal Antibodies and Patient Treatment Selection

A key opinion leader discusses the use of oral agents for the preventive treatment of migraine.

Jessica Ailani, MD;Stephanie J. Nahas, MD, MSEd;Rebecca Erwin Wells, MD, MPH;Andrew C. Charles, MD;Christopher Gottschalk, MD

December 31st 2021